Amgen (AMGN) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

75
on a 30–98 scale
ACCUMULATE
$467.06last close
-1score vs prior day
51–89range since 06-29
+29.5%price since 06-29

The entry score measures one thing: how far Amgen's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Amgen's price sits 1.07 ATR above its 20-day average ($454.20); it trades above its 200-day average ($380.39); its 14-day RSI is 67; it has moved +7.99% over 20 sessions; our regime filter classifies it as a strong uptrend.

Is Amgen (AMGN) a buy right now?

Amgen scores 75/98 (Accumulate) as of 2026-11-12; it is 2.4% below its 52-week high of $478.48; it is above its 200-day average; it moved +1.44% over the last 5 sessions. A mid-range score means the price is near its recent average: not a stretched entry, not a discount. Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1275-1$467.06
2026-11-0676+3$460.42
2026-11-0573+18$460.28
2026-11-0455-7$478.48
2026-11-0362+7$461.26
2026-11-0255+0$465.45
2026-10-2955-4$460.73
2026-10-2859-1$451.83
2026-10-2760-3$447.95
2026-10-2663-6$444.63
2026-10-2369+7$439.26
2026-10-2262-7$447.28

Congress trades in AMGN

STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.

TradedPoliticianTypeAmountReturn since
2026-10-15Sheldon Whitehouse (D)SALE$15,001 - $50,000+6.1%
2026-09-22David J. Taylor (R)BUY$1,001 - $15,000+12.2%
2026-08-26David J. Taylor (R)SALE$1,001 - $15,000+4.6%
2026-08-12Sheldon Whitehouse (D)SALE$1,001 - $15,000+10.6%
2026-07-08Rohit Khanna (D)BUY$1,001 - $15,000+25.1%

Related stocks

See today's full rankings + entry plan for AMGN →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.